These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6301764

  • 1. Hemodynamic responses to beta-adrenergic blockade with metoprolol and pindolol after coronary artery bypass surgery.
    Salmenperä M, Yrjölä H, Heikkilä J.
    Chest; 1983 May; 83(5):739-43. PubMed ID: 6301764
    [Abstract] [Full Text] [Related]

  • 2. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL.
    J Cardiovasc Pharmacol; 1983 May; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [Abstract] [Full Text] [Related]

  • 3. Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
    Heikkilä J, Nieminen MS.
    Am Heart J; 1982 Aug; 104(2 Pt 2):464-72. PubMed ID: 7102533
    [Abstract] [Full Text] [Related]

  • 4. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
    Silke B, Frais MA, Verma SP, Reynolds G, Taylor SH.
    Eur J Clin Pharmacol; 1986 Aug; 29(6):659-65. PubMed ID: 2872054
    [Abstract] [Full Text] [Related]

  • 5. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
    Svensson A, Gudbrandsson T, Sivertsson R, Hansson L.
    Acta Med Scand Suppl; 1982 Aug; 665():103-8. PubMed ID: 6760678
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes.
    Hansson L.
    Am J Cardiol; 1986 Feb 12; 57(5):29C-32C. PubMed ID: 3946248
    [Abstract] [Full Text] [Related]

  • 7. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH, Silke B, Lee PS.
    N Engl J Med; 1982 Mar 18; 306(11):631-5. PubMed ID: 6120457
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H, Otsuka K, Miyamoto K, Hashimoto M, Yasutake S.
    Jpn Circ J; 1976 Jun 18; 40(6):655-64. PubMed ID: 7688
    [Abstract] [Full Text] [Related]

  • 9. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE, Feldman RL, Hill JA, Pepine CJ.
    Am J Cardiol; 1987 Aug 01; 60(4):244-8. PubMed ID: 2887101
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of pindolol.
    Aellig WH.
    Am Heart J; 1982 Aug 01; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
    Aellig WH.
    J Cardiovasc Pharmacol; 1983 Aug 01; 5 Suppl 1():S16-20. PubMed ID: 6188915
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of intravenous metoprolol.
    Bourdillon PD, Canepa-Anson R, Rickards AF.
    Am J Cardiol; 1979 Nov 01; 44(6):1195-200. PubMed ID: 495515
    [Abstract] [Full Text] [Related]

  • 13. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
    Pasotti C, Capra A, Fiorella G, Vibelli C, Chierichetti SM.
    Br J Clin Pharmacol; 1982 Nov 01; 13(Suppl 2):435S-439S. PubMed ID: 7104157
    [Abstract] [Full Text] [Related]

  • 14. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery?
    Booth JV, Ward EE, Colgan KC, Funk BL, El-Moalem H, Smith MP, Milano C, Smith PK, Newman MF, Schwinn DA, Duke Heart Center Perioperative Desensitization Group.
    Anesth Analg; 2004 May 01; 98(5):1224-31, table of contents. PubMed ID: 15105192
    [Abstract] [Full Text] [Related]

  • 15. Pharmacologic differences between beta blockers.
    Wood AJ.
    Am Heart J; 1984 Oct 01; 108(4 Pt 2):1070-7. PubMed ID: 6148865
    [Abstract] [Full Text] [Related]

  • 16. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
    Ades PA, Wolfel EE, Hiatt WR, Fee C, Rolfs R, Brammell HL, Horwitz LD.
    Eur J Clin Pharmacol; 1989 Oct 01; 36(1):5-10. PubMed ID: 2917588
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hypertension with beta-blockers with and without intrinsic sympathomimetic activity.
    Hansson L, Svensson A, Gudbrandsson T, Sivertsson R.
    J Cardiovasc Pharmacol; 1983 Oct 01; 5 Suppl 1():S26-9. PubMed ID: 6188917
    [Abstract] [Full Text] [Related]

  • 18. Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
    Erikssen J, Thaulow E, Mundal R, Opstad P, Nitter-Hauge S.
    Br J Clin Pharmacol; 1982 Oct 01; 13(Suppl 2):201S-209S. PubMed ID: 6125171
    [Abstract] [Full Text] [Related]

  • 19. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
    Majid PA, Schreuder JE, de Feyter PJ, Roos JP.
    J Cardiovasc Pharmacol; 1980 Oct 01; 2(4):435-44. PubMed ID: 6156341
    [Abstract] [Full Text] [Related]

  • 20. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
    Wink K.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 01; 22(3):126-30. PubMed ID: 6715080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.